Castro, Maria G.
Maria G Castro
VIAF ID: 12533603 (Personal)
Permalink: http://viaf.org/viaf/12533603
Preferred Forms
- 200 _ | ‡a Castro ‡b Maria G.
-
- 100 1 _ ‡a Castro, Maria G.
-
-
-
- 100 1 _ ‡a Castro, Maria G.
- 100 0 _ ‡a Maria G Castro
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Gene therapy for neurological disorders | |
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells | |
Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo. | |
Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors | |
Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H. | |
The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors | |
Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1. | |
Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. | |
Mitochondrial haplogroup T is negatively associated with the status of elite endurance athlete | |
Multiple Expressed Endogenous Glioma Epitopes as Novel Vaccines for Gliomas | |
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer | |
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity | |
Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells | |
Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity | |
Neuronal expression of the transcription factor Gli1 using the Talpha1 alpha-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease. | |
Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene | |
Nuclear translocation of neuropeptides: possible nuclear roles | |
On the stimulatory nature of the control of MSH secretion in ducks. | |
Photoperiodic regulation of prolactin gene expression in the Syrian hamster by a pars tuberalis-derived factor. | |
Piry virus antibodies in inhabitants of Rio de Janeiro | |
Platelets mediate cytotoxic T lymphocyte-induced liver damage | |
Polarity development and synaptogenesis in low density primary cultures of neocortex. Use of herpes simplex virus-1 vectors to transfer genes into postmitotic neurons | |
Polarized Distribution of the Trans-Golgi Network Marker TGN38 During the In Vitro Development of Neocortical Neurons: Effects of Nocodazole and Brefeldin A | |
Politically correct gene therapy? A "clean environment" improves gene delivery to the brain! | |
Post-translational processing of proopiomelanocortin in the pituitary and in the brain | |
Potential impact of a presumed increase in the biting activity of dengue-virus-infected Aedes aegypti (Diptera: Culicidae) females on virus transmission dynamics. | |
Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy | |
Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model | |
Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors | |
Presence of pro-vasopressin mRNA, neurophysin and arginine vasopressin in mouse anterior pituitary cells and the AtT-20 corticotrophic tumour cell line | |
Pro-opiomelanocortin and pro-vasopressin converting enzyme in pituitary secretory vesicles. | |
Processing of Procorticotropin-Releasing Hormone (Pro-CRH): Molecular Forms of CRH in Normal and Preeclamptic Pregnancy1 | |
Procorticotrophin-releasing hormone: endoproteolytic processing and differential release of its derived peptides within AtT20 cells. | |
Production and release of corticotropin releasing hormone (CRH) from AtT-20 cells stably transfected with the human CRH gene | |
Progesterone antagonizes the permissive action of estradiol on tumor necrosis factor-alpha-induced apoptosis of anterior pituitary cells. | |
Prohormone and proneuropeptide synthesis and secretion. | |
PTPS-15ATRX LOSS PROMOTES TUMOR GROWTH AND IMPAIRS NON-HOMOLOGOUS END JOINING DNA REPAIR IN GLIOMA. | |
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma | |
Pushing the limits of glioma resection using electrophysiologic brain mapping | |
Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction. | |
Real-time imaging of gene promoter activity using an adenoviral reporter construct demonstrates transcriptional dynamics in normal anterior pituitary cells. | |
Recent advances and future of immunotherapy for glioblastoma | |
Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppresses growth of estrogen-induced pituitary prolactinomas | |
The regulation of the corticomelanotropic cell activity in aves. III--Effect of various peptides on the release of MSH from dispersed, perfused duck pituitary cells. Cosecretion of ACTH with MSH. | |
Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a disco | |
Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins | |
Single vs. combination immunotherapeutic strategies for glioma. | |
Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment | |
Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses | |
Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo | |
Studies on the prolactin-releasing mechanism of histones H2A and H2B | |
Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidylinositol (GPI) membrane anchor in neurons and polarised epithelial cells | |
Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism. | |
Synaptogenesis and distribution of presynaptic axonal varicosities in low density primary cultures of neocortex: an immunocytochemical study utilizing synaptic vesicle-specific antibodies, and an electrophysiological examination utilizing whole cell | |
Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma | |
Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas | |
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy | |
T cells' immunological synapses induce polarization of brain astrocytes in vivo and in vitro: a novel astrocyte response mechanism to cellular injury | |
Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation. | |
Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models | |
Thymosin peptides stimulate corticotropin release by a calcium-dependent mechanism | |
Thymus-pituitary interactions during ageing. | |
Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. | |
Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS. | |
Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplastic anterior pituitaries | |
Transgenic models in endocrinology, c2001: | |
Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells | |
Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma | |
Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand | |
Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials | |
Uptake of alpha-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro | |
Use of gene transfer to study post-translational modifications of neuropeptides in cell lines | |
The use of inclusion bodies, isolated from Escherichia coli expressing corticotrophin-releasing hormone precursor, to raise specific antibodies against the neuropeptide moiety | |
Use of recombinant adenovirus for gene transfer into the rat brain. Evaluation of gene transfer efficiency, toxicity, and inflammatory and immune reactions | |
Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro | |
The value of EGFRvIII as the target for glioma vaccines. | |
γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. |